共 50 条
- [41] Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL StudyTARGETED ONCOLOGY, 2021, 16 (06) : 761 - 771Hawkes, Eliza A.论文数: 0 引用数: 0 h-index: 0机构: Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, Australia Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, Australia论文数: 引用数: h-index:机构:Budde, Lihua Elizabeth论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Duarte, CA USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaSantoro, Armando论文数: 0 引用数: 0 h-index: 0机构: Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy Humanitas Clin & Res Ctr IRCCS, Rozzano Milano, Italy Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaSaba, Nakhle S.论文数: 0 引用数: 0 h-index: 0机构: Tulane Univ, Deming Dept Med, Sect Hematol & Med Oncol, New Orleans, LA USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaRoncolato, Fernando论文数: 0 引用数: 0 h-index: 0机构: St George Hosp, Kogarah, NSW, Australia Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaGregory, Gareth P.论文数: 0 引用数: 0 h-index: 0机构: Monash Univ, Sch Clin Sci Monash Hlth, Melbourne, Vic, Australia Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaVerhoef, Gregor论文数: 0 引用数: 0 h-index: 0机构: UZ Leuven, Leuven, Belgium Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaOffner, Fritz论文数: 0 引用数: 0 h-index: 0机构: UZ Gent, Ghent, Belgium Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaQuero, Cristina论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Victoria, Malaga, Spain Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, Australia论文数: 引用数: h-index:机构:Giannopoulos, Krzysztof论文数: 0 引用数: 0 h-index: 0机构: Med Univ Lublin, Expt Hematooncol Dept, St Johns Canc Ctr, Lublin, Poland Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaStevens, Don论文数: 0 引用数: 0 h-index: 0机构: Norton Canc Inst, Louisville, KY USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaThall, Aron论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, La Jolla, CA USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaHuang, Bo论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Groton, CT 06340 USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaLaird, A. Douglas论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, La Jolla, CA USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaSandner, Robin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Collegeville, PA USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, AustraliaAnsell, Stephen M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Austin Hlth, Olivia Newton John Canc Res Inst, 145 Studley Rd, Heidelberg, Vic, Australia
- [42] Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population in a Phase Ib/II TrialBLOOD, 2019, 134Diefenbach, Catherine论文数: 0 引用数: 0 h-index: 0机构: NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAKahl, Brad S.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Div Oncol, St Louis, MO 63110 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USABanerjee, Lalita论文数: 0 引用数: 0 h-index: 0机构: Maidstone & Tunbridge Wells NHS Trust, Ctr Oncol, Maidstone, Kent, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMcMillan, Andrew K.论文数: 0 引用数: 0 h-index: 0机构: Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMiall, Fiona论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leicester NHS Trust, Dept Haematol, Leicester, Leics, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USABriones, Javier论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USACordoba, Raul论文数: 0 引用数: 0 h-index: 0机构: Fdn Jimenez Diaz Univ Hosp, Madrid, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAHirata, Jamie论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAChang, YiMeng论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche Ltd, Mississauga, ON, Canada NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMusick, Lisa论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAAbrisqueta, Pau论文数: 0 引用数: 0 h-index: 0机构: Hosp Valle De Hebron, Barcelona, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
- [43] Phase Ib/II trial of polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed/refractory follicular lymphoma: primary analysis of the full efficacy populationBRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 113 - 114Diefenbach, C. S.论文数: 0 引用数: 0 h-index: 0机构: NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMcMillan, A.论文数: 0 引用数: 0 h-index: 0机构: Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAKahl, B. S.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, St Louis, MO 63110 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMiall, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leicester, Leicester, Leics, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USABanerjee, L.论文数: 0 引用数: 0 h-index: 0机构: Maidstone & Tunbridge Wells NHS Trust, Oncol Ctr, Tunbridge Wells, Kent, England NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USABriones, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu & Sant Pau, Barcelona, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USACordoba, R.论文数: 0 引用数: 0 h-index: 0机构: Fdn Jimenez Diaz Univ Hosp, Madrid, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAAbrisqueta, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Valle De Hebron, Barecelona, Spain NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAHirata, J.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAChang, Y.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Mississauga, ON, Canada NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USAMusick, L.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
- [44] Initial results from an international study in relapsed/refractory aggressive non-Hodgkin's lymphoma to confirm the activity, safety and criteria for predicting response to lenalidomide monotherapyBLOOD, 2007, 110 (11) : 758A - 758AWilzig, Thomas E.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Mayo Clin, Rochester, MN USAReeder, Craig B.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USA Mayo Clin, Rochester, MN USAPolikoff, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Kaiser Permanente Med Grp, San Diego, CA USA Mayo Clin, Rochester, MN USAChowhan, Naveed M.论文数: 0 引用数: 0 h-index: 0机构: Canc Care Ctr, New Albany, IN USA Mayo Clin, Rochester, MN USAEsseessee, Isaac论文数: 0 引用数: 0 h-index: 0机构: Hematol Oncol Associates Cent Brevard, Rockledge, FL USA Mayo Clin, Rochester, MN USAGreenberg, Richard论文数: 0 引用数: 0 h-index: 0机构: Ctr Canc & Hematol Dis, Cherry Hill, NJ USA Mayo Clin, Rochester, MN USAPatel, Hermant论文数: 0 引用数: 0 h-index: 0机构: NW Alabama Canc Ctr, Muscle Shoals, AL USA Mayo Clin, Rochester, MN USAVafai, Davood论文数: 0 引用数: 0 h-index: 0机构: Access Clin Res, Rancho Mirage, CA USA Mayo Clin, Rochester, MN USAWiernik, Peter H.论文数: 0 引用数: 0 h-index: 0机构: New York Med Coll, Our Lady Mercy Canc Ctr, Bronx, NY USA Mayo Clin, Rochester, MN USAErvin-Haynes, Annette论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Mayo Clin, Rochester, MN USAPietronigro, Dennis论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Mayo Clin, Rochester, MN USAZeldis, Jerome B.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Mayo Clin, Rochester, MN USACzuczman, Myron论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Buffalo, NY 14263 USA Mayo Clin, Rochester, MN USA
- [45] Subcutaneous Mosunetuzumab Is Active with a Manageable Safety Profile in Patients (pts) with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphomas (B-NHLs): Updated Results from a Phase I/II StudyBLOOD, 2022, 140 : 3753 - 3755Budde, Elizabeth L.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USABartlett, Nancy L.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAGiri, Pratyush论文数: 0 引用数: 0 h-index: 0机构: Royal Adelaide Hosp, Adelaide, SA, Australia City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USASchuster, Stephen J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAAssouline, Sarit论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAYoon, Sung-Soo论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Seoul, South Korea City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAFay, Keith论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp, Sydney, NSW, Australia Royal North Shore Hosp, Sydney, NSW, Australia City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAMatasar, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAGutierrez, Norma C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAMarlton, Paula论文数: 0 引用数: 0 h-index: 0机构: Princess Alexandra Hosp, Brisbane, Qld, Australia Univ Queensland, Brisbane, Qld, Australia City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USADreyling, Martin论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ Munchen, Hosp Munich, Munich, Germany City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAYoon, Dok Hyun论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA论文数: 引用数: h-index:机构:Radford, John论文数: 0 引用数: 0 h-index: 0机构: Christie NHS Fdn Trust, Manchester, Lancs, England City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAWiebking, Volker论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAYin, Shen论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USACybulski, Eva论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USATurner, David C.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAHuang, Huang论文数: 0 引用数: 0 h-index: 0机构: Hoffmann La Roche Ltd, Mississauga, ON, Canada City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAZhou, Mingzhu论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Shanghai, Peoples R China City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAPenuel, Elicia论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAWei, Michael C.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USASehn, Laurie H.论文数: 0 引用数: 0 h-index: 0机构: BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada Univ British Columbia, Vancouver, BC, Canada City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
- [46] Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS.BLOOD, 2010, 116 (21) : 1252 - 1252Corso, Alessandro论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyMangiacavalli, Silvia论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyCocito, Federica论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyPascutto, Cristiana论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyAstori, Cesare论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyVarettoni, Marzia论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyOrlandi, Ester论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyZappasodi, Patrizia论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyRizzi, Silvia论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyAmbaglio, Ilaria论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyLazzarino, Mario论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, ItalyCazzola, Mario论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy Univ Pavia, Div Hematol, Dept Oncohematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
- [47] A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B-and T-Cell LymphomasBLOOD, 2017, 130Mehta-Shah, Neha论文数: 0 引用数: 0 h-index: 0Moskowitz, Alison J.论文数: 0 引用数: 0 h-index: 0Lunning, Matthew A.论文数: 0 引用数: 0 h-index: 0Lynch, Peggy论文数: 0 引用数: 0 h-index: 0Scheuerman, Mark论文数: 0 引用数: 0 h-index: 0Minnal, Veenna论文数: 0 引用数: 0 h-index: 0Galasso, Natasha论文数: 0 引用数: 0 h-index: 0Kumar, Anita论文数: 0 引用数: 0 h-index: 0Gerecitano, John论文数: 0 引用数: 0 h-index: 0Zelenetz, Andrew D.论文数: 0 引用数: 0 h-index: 0Hamlin, Paul A.论文数: 0 引用数: 0 h-index: 0Noy, Ariela论文数: 0 引用数: 0 h-index: 0Matasar, Matthew J.论文数: 0 引用数: 0 h-index: 0Palomba, Maria Lia论文数: 0 引用数: 0 h-index: 0Younes, Anas论文数: 0 引用数: 0 h-index: 0Schaffer, Wendy论文数: 0 引用数: 0 h-index: 0Grewal, Ravinder论文数: 0 引用数: 0 h-index: 0Rademaker, Jurgen论文数: 0 引用数: 0 h-index: 0Sauter, Craig S.论文数: 0 引用数: 0 h-index: 0Dahi, Parastoo B.论文数: 0 引用数: 0 h-index: 0Myskowski, Patricia论文数: 0 引用数: 0 h-index: 0Kheterpal, Meenal论文数: 0 引用数: 0 h-index: 0Dogan, Ahmet论文数: 0 引用数: 0 h-index: 0Pulitzer, Melissa论文数: 0 引用数: 0 h-index: 0Lubin, Lakeisha论文数: 0 引用数: 0 h-index: 0Tang, Laura论文数: 0 引用数: 0 h-index: 0Ganesan, Nivetha论文数: 0 引用数: 0 h-index: 0Ni, Ai论文数: 0 引用数: 0 h-index: 0Horwitz, Steven M.论文数: 0 引用数: 0 h-index: 0
- [48] Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b StudyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E443 - E451Palomba, M. Lia论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USATill, Brian G.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAPark, Steven I.论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAMorschhauser, Franck论文数: 0 引用数: 0 h-index: 0机构: Lille Univ Hosp Ctr, Dept Clin Hematol, Lille, France Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USACartron, Guillaume论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ctr Montpellier, Dept Clin Hematol, Montpellier, France Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAMarks, Reinhard论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Dept Hematol, Oncol & Stem Cell Transplantat, Freiburg, Germany Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAShivhare, Mahesh论文数: 0 引用数: 0 h-index: 0机构: Roche Prod, Welwyn Garden City, Herts, England Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAHong, Wan-Jen论文数: 0 引用数: 0 h-index: 0机构: Oncol Biomarker Dev Genentech Inc, South San Francisco, CA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USARaval, Aparna论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Lymphoma Div, Dept Hematol & Hematopoit Cell Transplantat, Duarte, CA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAChang, Alice C.论文数: 0 引用数: 0 h-index: 0机构: Oncol Biomarker Dev Genentech Inc, South San Francisco, CA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAPenuel, Elicia论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Lymphoma Div, Dept Hematol & Hematopoit Cell Transplantat, Duarte, CA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAPopplewell, Leslie L.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Hematol & Hematopoiet Cell Transplantat, 1500 East Duarte Rd, Duarte, CA USA Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
- [49] Results of a phase I study of RAD001 in combination with lenalidomide in patients with relapsed or refractory multiple myclomaJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Mahindra, A. K.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USARichardson, P. G.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USAHari, P.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USALaubach, J.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USAGhobrial, I. M.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USASchlossman, R. L.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USAWeller, E.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USAMunshi, N. C.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USAAnderson, K. C.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USARaje, N. S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
- [50] Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II studyInternational Journal of Hematology, 2023, 117 : 100 - 109Noriko Fukuhara论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyDai Maruyama论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyKiyohiko Hatake论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyHirokazu Nagai论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyShinichi Makita论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyKenjiro Kamezaki论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyToshiki Uchida论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyShigeru Kusumoto论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyJunya Kuroda论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyChisako Iriyama论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyMasamitsu Yanada论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyNorifumi Tsukamoto论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyYouko Suehiro论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyHironobu Minami论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyJose Garcia-Vargas论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyBarrett H. Childs论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyMasanobu Yasuda论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyShigeo Masuda论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyToshiaki Tsujino论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyYui Terao论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of HematologyKensei Tobinai论文数: 0 引用数: 0 h-index: 0机构: Tohoku University Hospital,Department of Hematology